2023
DOI: 10.20892/j.issn.2095-3941.2023.0129
|View full text |Cite
|
Sign up to set email alerts
|

Deciphering gastric inflammation-induced tumorigenesis through multi-omics data and AI methods

Qian Zhang,
Mingran Yang,
Peng Zhang
et al.

Abstract: Gastric cancer (GC), the fifth most common cancer globally, remains the leading cause of cancer deaths worldwide. Inflammation-induced tumorigenesis is the predominant process in GC development; therefore, systematic research in this area should improve understanding of the biological mechanisms that initiate GC development and promote cancer hallmarks. Here, we summarize biological knowledge regarding gastric inflammation-induced tumorigenesis, and characterize the multi-omics data and systems biology methods… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
1

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 119 publications
1
1
0
Order By: Relevance
“…After confirming the genotypic evolution trajectory, Curtis et al further applied single cell sequencing (sc-RNA) to decipher the reprogramming of transcriptional signatures initiated by TP53 deficiency. As expected, when compared with wild-type HGOs and a normal mucosal gene expression signature, such as MUC5AC , TFF1 , and TFF2 , those TP53 −/− HGOs stepwise reduce expression of these markers but gradually acquire GC-associated signatures, including increased expression of claudins ( CLDN3/4/7 ) and carcinoembryonic antigen ( CEACAM5 / 6 ), which phenocopy the molecular events as detected in gastric tumorigenesis models in vivo 17 , 18 . Moreover, the transcriptional comparison between early, middle, and late phases of the same TP53 −/− HGOs consistently identified 13 consistently upregulated genes, such as CLDN4 , TM4SF1 , and ZFAS1 , suggesting these factors are required for the establishment of neoplasia status ( Figure 1B ).…”
Section: Tp53 Loss-driven Dynamic Clonal Evolution In Vitrosupporting
confidence: 66%
“…After confirming the genotypic evolution trajectory, Curtis et al further applied single cell sequencing (sc-RNA) to decipher the reprogramming of transcriptional signatures initiated by TP53 deficiency. As expected, when compared with wild-type HGOs and a normal mucosal gene expression signature, such as MUC5AC , TFF1 , and TFF2 , those TP53 −/− HGOs stepwise reduce expression of these markers but gradually acquire GC-associated signatures, including increased expression of claudins ( CLDN3/4/7 ) and carcinoembryonic antigen ( CEACAM5 / 6 ), which phenocopy the molecular events as detected in gastric tumorigenesis models in vivo 17 , 18 . Moreover, the transcriptional comparison between early, middle, and late phases of the same TP53 −/− HGOs consistently identified 13 consistently upregulated genes, such as CLDN4 , TM4SF1 , and ZFAS1 , suggesting these factors are required for the establishment of neoplasia status ( Figure 1B ).…”
Section: Tp53 Loss-driven Dynamic Clonal Evolution In Vitrosupporting
confidence: 66%
“…The selection of baseline characteristics is based on individuals aged ≥ 45 who meet any of the following criteria, which are indicative of a high-risk profile for gastric cancer: 1) Long-term residence in high-incidence areas of gastric cancer; 2) Hp infection; 3) History of chronic atrophic gastritis, gastric ulcer, gastric polyp, residual stomach after surgery, hypertrophic gastritis, pernicious anemia, or other precancerous diseases of the stomach; 4) First-degree relatives with a history of gastric cancer; 5) Presence of other high-risk factors for gastric cancer such as high salt intake, pickled diet, smoking, and heavy alcohol consumption [25][26][27][28]. Since our screening is conducted in high-risk areas, we ignore the first criterion.…”
Section: Comparison Of the Aitonguequiry Model Single Modality Models...mentioning
confidence: 99%